| Date Filed | Type | Description |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Goldsmith Bruce A (CEO and President) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Bought 10,000 shares
@ $3.15, valued at
$31.5k
|
|
| 02/14/2022 |
4
| Goldsmith Bruce A (CEO and President) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 400,000 options to buy
@ $4.52, valued at
$1.8M
|
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/05/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2012 |
4
| Goldsmith Bruce A (SVP, Corporate Development) has filed a Form 4 on ALLOS THERAPEUTICS INC|
Txns:
| Granted 179,727 shares
@ $0
Sold 4,505 shares
@ $1.5248, valued at
$6.9k
Sold 4,473 shares
@ $1.4957, valued at
$6.7k
|
|
| 02/27/2012 |
4
| Goldsmith Bruce A (SVP, Corporate Development) has filed a Form 4 on ALLOS THERAPEUTICS INC|
Txns:
| Sold 2,500 shares
@ $1.5832, valued at
$4k
Sold 575 shares
@ $1.5445, valued at
$888.1 |
|
| 11/17/2011 |
4
| Goldsmith Bruce A (SVP, Corporate Development) has filed a Form 4 on ALLOS THERAPEUTICS INC|
Txns:
| Sold 12,465 shares
@ $1.4447, valued at
$18k
Sold 300 shares
@ $1.4317, valued at
$429.5 |
|
| 03/02/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/22/2010 |
4
| Goldsmith Bruce A (VP, Corporate Development) has filed a Form 4 on ALLOS THERAPEUTICS INC|
Txns:
| Granted 100,671 shares
@ $0 |
|
| 09/15/2010 |
3/A
| Goldsmith Bruce A (VP, Corporate Development) has filed a Form 3/A on ALLOS THERAPEUTICS INC |
| 09/03/2010 |
3
| Goldsmith Bruce A (VP, Corporate Development) has filed a Form 3 on ALLOS THERAPEUTICS INC |